The total number of COVID-19 cases in the country mounted to 56,342 with 3,390 new cases and 103 deaths in the last 24 hours.
As on May 7, India’s Covid-19 tally is 52,952, a spike of 3,561 cases. Eighty nine persons have died, taking the toll from 1,694 on May 6 to 1,783 on May 7. This is the second largest day-to-day increase in case numbers following May 5 when 3,875 new cases were recorded on a single day.
Of the confirmed cases, 15,267 have recovered, according to the Ministry of Health and Family Welfare.
Union Health Minister, Harsh Vardhan stated that 1.1 per cent of the cases were on ventilator; 3.3 per cent were receiving oxygen therapy and 4.8 per cent patients were admitted in intensive care units.
Harsh Vardhan reviewed Uttar Pradesh’s preparedness and ground situation and said 66 of the 75 districts had Covid-19 cases. As on May 7, UP recorded 2,998 confirmed cases, with 1,130 recoveries and 60 deaths.
Vardhan told state officials that they should ramp up their severe acute respiratory illness (SARI) and influenza-like illness (ILI) surveillance. Harsh Vardhan also said that Ministry of Ayurveda, Yoga, Unani, Siddha and Homeopathy (AYUSH) had launched four clinical trials to study the effect of interventions like Ashwagandha, Yashtimadhu, Guduchi - Pippali and poly herbal formulation (AYUSH-64) in 25 states and in a population of five lakh to assess preventive potential of these interventions and improvement in quality of life in high-risk population.
According to the Ministry of AYUSH, one of the trials pits Ashwagandha against allopathy drug Hydroxychloroquine to see if it can be an effective preventive treatment in health care providers.
